25.700
+1,18%
2026-10-16
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -90.9% | -42.9% | 0 / 3 | -21.3% | -6.31 pp | -8.34 pp | +13.8% | 0.29 | 6.95 | 363 | −21,3% | 1,8 | −95,6% | 6.95 | 6.25 | +11,1% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 25.700 (close price on 2026-10-16)EPS (TTM): 3.700
Financial charts
1.Revenue & growth
VND bn363Q2/26
1.Revenue & growth
VND bn363Q2/26
2.Profit & growth
VND bn3,36Q2/26
3.Profit mix (Penman)
VND bn124Q2/26
4.Margins & cost structure
%14.6%Q2/26
5.Returns & cash cycle
% · days13.6%Q2/26
6.Earnings quality & cash
VND bn42,7Q2/26
7.Asset structure
VND bn1.145Q2/26
8.Funding & debt health
VND bn · times1.145Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %6,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %135Q2/26
Adjusted EPS growth, latest quarter
-90.9%
Average adjusted EPS growth, 3 quarters
-42.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26